Patients' practices and experiences of using nebuliser therapy in the management of COPD at home
B Alhaddad, FJ Smith, T Robertson… - BMJ open …, 2015 - bmjopenrespres.bmj.com
Background and aim How patients use their nebulisers at home is vital to ensure effective
treatment and optimal health outcomes for patients with chronic obstructive pulmonary …
treatment and optimal health outcomes for patients with chronic obstructive pulmonary …
Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease
SK Barta, A Crawford, CM Roberts - Respiratory medicine, 2002 - Elsevier
There is some controversy amongst respiratory physicians over the value of domiciliary
nebuliser use for chronic lung conditions. Most recommendations for assessment of …
nebuliser use for chronic lung conditions. Most recommendations for assessment of …
[HTML][HTML] Guiding principles for the use of nebulized long-acting beta2-agonists in patients with COPD: an expert panel consensus
RA Wise, RA Acevedo, AR Anzueto… - … Diseases: Journal of …, 2017 - ncbi.nlm.nih.gov
Determining which patients with COPD may benefit from a nebulized long-acting beta2-
agonist (LABA) is a challenge in current practice. In the absence of strong clinical guidelines …
agonist (LABA) is a challenge in current practice. In the absence of strong clinical guidelines …
14. EDUCATION AND STAFF TRAINING
K Heslop, L Lannefors - api.taylorfrancis.com
Inhalation therapy is developing rapidly and many improvements in nebulizer technology
have been made. However, the success of nebulizer treatment is dependent on the …
have been made. However, the success of nebulizer treatment is dependent on the …
[图书][B] The use of nebulisers in the home: a study with patients and carers
BJ Alhaddad - 2012 - search.proquest.com
Introduction: Inhalational therapy is the mainstay of treatment for COPD, and nebuliser
therapy is commonly prescribed for the management of severe COPD in the home. The …
therapy is commonly prescribed for the management of severe COPD in the home. The …
Nebulizer use in chronic asthma and obstructive
EUSEINHS BSTRUCTIVE, IIJP Karpel… - TNF-Inhibition in the …, 2004 - taylorfrancis.com
In the United States of America (USA) total healthcare costs for asthma were estimated to be
$12.7 billion for 2001. Of this, $2.4 billion were attributed to treatment costs (Figure 5.1). 1 …
$12.7 billion for 2001. Of this, $2.4 billion were attributed to treatment costs (Figure 5.1). 1 …
[引用][C] TNF [alpha]-inhibition in the treatment of rheumatoid arthritis
LW Moreland, P Emery - (No Title), 2003 - cir.nii.ac.jp
TNF[alpha]-inhibition in the treatment of rheumatoid arthritis | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …